Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
0.3980
+0.0079 (2.03%)
At close: Nov 6, 2026, 4:00 PM EST
0.3993
+0.0013 (0.33%)
After-hours: Nov 6, 2026, 7:17 PM EST
Lucid Diagnostics Market Cap
Lucid Diagnostics has a market cap or net worth of $76 million as of November 6, 2026. It is the 26,793rd most valuable company in the world and the 4,282nd biggest in the United States. Its market cap has decreased by 46.63% in one year.
Market Cap
76.00M
Enterprise Value
66.43M
1-Year Change
-46.63%
Global Rank
Country Rank
#4,282 United States
Category
ChartMarket Cap Chart
Since the IPO on October 14, 2021, Lucid Diagnostics's market cap has decreased from $514.14M to $76.00M, a decrease of -85.22%. That is a compound annual growth rate of -31.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 76.00M | -46.82% |
| Dec 31, 2025 | 142.90M | 214.80% |
| Dec 31, 2024 | 45.39M | -23.95% |
| Dec 29, 2023 | 59.69M | 12.22% |
| Dec 30, 2022 | 53.19M | -73.09% |
| Dec 31, 2021 | 197.66M | -61.55% |
| Oct 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pulmonx | 109.95M |
| Perspective Therapeutics | 95.89M |
| Nyxoah | 89.41M |
| Sera Prognostics | 84.03M |
| Outset Medical | 78.57M |
| Hyperfine | 76.52M |
| Microbot Medical | 75.22M |
| electroCore | 67.53M |